Delivery Order SPE2DB22D1002-SPE2DB24FLEF5

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $18,190.23 awarded by the Defense Logistics Agency (DLA). The contract covers the supply of DESCOVY 200-25 MG TABLET, a pharmaceutical product, and has an ultimate completion date of November 26, 2024. The contract was awarded on November 25, 2024 and is a Firm Fixed Price arrangement. This Delivery Order appears to be part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $18,236.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the product "DESCOVY 200-25 MG TABLET UU 30S" and has an ultimate completion date of January 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $19,501.58 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This award is a task order under Amerisourcebergen's single-award Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products, including specialty, brand name, generic,...
This federal contract award, valued at $7,338.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $58,115.71, is a delivery order for the medical product "DESCOVY 200-25 MG TABLET UU 30S". The contract has a firm fixed price and an ultimate completion date of December 19, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, with ID SPE2DX15D3110|SPE2DX25F21NL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,557.88 firm fixed-price delivery order is for the medical product "DESCOVY 200-25 MG TABLET UU 30S" and has a completion date of November 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,641.36 firm fixed-price delivery order is for DESCOVY 200-25 MG TABLET UU 30S, a medical product. The contract has an ultimate completion date of June 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $25,761.15 for the supply of the drug Descovy 200-25 mg Tablet. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 20, 2025. The contract is a Firm Fixed Price agreement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of DESCOVY 200-25 MG TABLET. The contract, valued at $12,837.86, is a firm fixed price delivery order with a completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This federal contract award, valued at $10,593.79, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the product "DESCOVY 200-25 MG TABLET UU 30S" and has a completion date of December 19, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLEF5
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order worth $10,141.18 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the pharmaceutical product "DESCOVY 200-25 MG TABLET UU 30S", with an ultimate completion date of July 2, 2024. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant IDC with the DLA, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:04 AM